Notre Dame Loses Protection From Endowment Tax in GOP Bill
But a loophole for religious schools was removed from the final tax bill, leaving the South Bend, Indiana-based school to pay a higher levy on its $20 billion endowment.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
11 minutes ago
- Yahoo
Epstein associate Ghislaine Maxwell moved to Texas prison
Ghislaine Maxwell, an associate of child sex offender Jeffrey Epstein, has been transferred from a prison in the southern US state of Florida to a lower security facility in Texas, the Bureau of Prisons announced Friday. Maxwell's lawyer, David Markus, also confirmed to the Reuters news agency that she had been transferred to the new facility. Maxwell is currently serving a 20 year sentence behind bars on charges of child sex trafficking. She is accused of grooming underage girls for Epstein to sexually abuse. US authorities did not explain the reason why Maxwell was transferred to a new facility in Bryan, Texas. She was earlier imprisoned at FCI Tallahassee in Tallahassee, Florida. The minimum-security Federal Prison Camp Bryan where Maxwell is now housed has better conditions than the low-security FCI Tallahassee in Florida. Federal Prison Camp Bryan has little to no perimeter fencing and a lower staff-to-inmate ratio, whereas FCI Tallahassee has double-fenced perimeters fencing and more prison staff on site. How have Epstein and Maxwell victims reacted? Victims of Epstein and Maxwell have condemned Maxwell's move to a lower-security prison. "Ghislaine Maxwell is a sexual predator who physically assaulted minor children on multiple occasions, and she should never be shown any leniency," Annie and Marie Farmer and the family of Virginia Giuffre said in response to the transfer. They said the transfer "smacks of a cover up." Annie and Marie Farmer have accused Epstein of molestation, whereas Giuffre has alleged that she was sex trafficked by Epstein to Prince Andrew, a member of the British royal family. Giuffre took her own life in April. Maxwell's transfer comes as Trump admin faces 'Epstein files' firestorm The transfer occurred after Maxwell recently met with US Deputy Attorney General Todd Blanche. It comes as Maxwell is appealing her prison sentence and the US President Donald Trump's administration is facing criticism over its handling of the Epstein case. Last month, the US Justice Department said that Epstein did not have a "client list" and that he did indeed kill himself in his prison cell in 2019. Both of those claims were met with skepticism from many Trump supporters, who urged the Trump administration to release more information on the Epstein case. The scandal regarding the so-called "Epstein files" is of a personal nature for Trump, who once was friends with Epstein. The disgraced New York financier had even said he was Trump's "closest friend" in recordings released by author Michael Wolff last year. The meetings between Blanche and Maxwell recently have sparked rumors that Trump could use presidential pardon powers to legally forgive Maxwell's federal charges. Trump has claimed he has the authority to pardon Maxwell, although Virginia Giuffre's family have urged him not to do so. Trump said in an interview with conservative US outlet Newsmax that "nobody's asked" him to pardon Maxwell. Edited by: Rana Taha
Yahoo
11 minutes ago
- Yahoo
OLIVE YOUNG Brings Leading K-Beauty Brands and "All Live Young" Philosophy to KCON LA 2025 as Title Sponsor
LOS ANGELES, Aug. 1, 2025 /PRNewswire/ -- OLIVE YOUNG, South Korea's leading beauty and wellness retailer, returns as the title sponsor of KCON LA 2025, bringing its signature "All Live Young" philosophy to life through a dynamic and immersive K-beauty experience in the heart of Los Angeles. This activation marks a major milestone in the brand's journey to bring its trusted K-beauty experience to North America, with its first U.S. store set to open in Los Angeles in late H1 2026. The brand's presence at KCON reflects its commitment to making K-beauty more accessible, inclusive, and experience-driven for global audiences. At KCON LA, OLIVE YOUNG will spotlight a total of 66 brands including their award-winning private label brands—BIOHEAL BOH, BRINGGREEN, and COLORGRAM— where 164 products from 64 brands will be featured through immersive, interactive zones designed to introduce U.S. audiences to the brand's curated approach to skincare, color, and wellness. Booth Highlights Include:K-Skincare Starter Kit: "Beauty Box" Pop-Up with Global App IntegrationAs part of the pop-up experience, attendees are invited to discover OLIVE YOUNG's "Beauty Box," a curated starter kit featuring standout products from six K-beauty brands available in the U.S. assortment, including Biodance, numbuzin, and ROUND LAB. Guests who engage in the experience will have the opportunity to extend their discovery journey through the OLIVE YOUNG Global website and app, where a limited-time exclusive chance to explore a pop-up offering will be available. Core Skincare Showcase: A Glimpse into the First U.S. StoreA dedicated zone spotlights OLIVE YOUNG's four essential skincare categories—Essence & Serum, Sun Care, Sheet Masks & Pads, and Creams—offering a first look at hero SKUs likely to be included in the upcoming U.S. retail launch.. Exclusive Experience Zones: Discover OLIVE YOUNG's Private BrandsVisitors can immerse themselves in interactive brand zones from OLIVE YOUNG's top-performing private labels: BIOHEAL BOH: Explore anti-aging and lifting solutions in the BIOHEAL BOH Lab. BRINGGREEN: Get personalized skin trouble diagnosis at the BRINGGREEN Nurse's Office. COLORGRAM: Play with high-quality color at COLORGRAM's Colorful Art Room. "We're excited to bring our 'All Live Young' philosophy to life at KCON LA 2025 through curated products, thoughtful retail innovation, and a focus on experience," said Sehoon Jin, Executive Vice President of Global Platform Business at OLIVE YOUNG. "This is a meaningful step in bringing OLIVE YOUNG's trusted and inclusive K-beauty experience to the U.S. market." For more information about OLIVE YOUNG and its private label brands, visit ABOUT OLIVE YOUNG: Established in 1999, OLIVE YOUNG is South Korea's leading beauty and health retailer, dedicated to helping everyone live a healthy and beautiful life. The brand philosophy, "All Live Young," reflects OLIVE YOUNG's vision of inspiring customers to embrace wellness and beauty at every stage of life. Through its flagship store and online platforms, OLIVE YOUNG offers a curated selection of trendy and innovative K-beauty and wellness products, loved by customers worldwide. With over 1,370 stores, more than 20 years of expertise, and strong global partnerships, OLIVE YOUNG continues to set the standard for innovation, accessibility, and customer-focused retail in the K-beauty and wellness industry. As part of CJ Group, a global lifestyle company based in South Korea, OLIVE YOUNG delivers the value of healthy beauty to customers everywhere. MEDIA CONTACT: For more information and interview requests, please contact PURPLE: oliveyoung@ View original content to download multimedia: SOURCE OLIVE YOUNG Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
11 minutes ago
- Yahoo
DEA Accountability as Cannabis Research Crisis Deepens And Patients Suffer
With the confirmation of incoming DEA Administrator Terrance Cole, the opportunity for reform has arrived. The DEA must choose between outdated drug war politics and advancing public health. MMJ International Holdings Issues Clarification on Irvine Labs. WASHINGTON, DC / / August 1, 2025 / MMJ International Holdings, Inc. ("MMJ") today issued a public clarification regarding prior statements about Irvine Labs, Inc., while calling for an urgent reckoning with the U.S. Drug Enforcement Administration's (DEA) catastrophic mismanagement of America's cannabis research policy. In a previous press release, MMJ referenced widespread inactivity among DEA-registered marijuana manufacturers. While these statements were intended to highlight systemic failures within the DEA's quota and licensing system, MMJ acknowledges that this language may have unintentionally caused confusion regarding Irvine Labs, Inc. MMJ hereby clarifies that Irvine Labs, Inc. is a registered DEA entity and, to the best of MMJ's current knowledge, holds valid DEA registrations. MMJ did not intend to imply that Irvine Labs is inactive or insolvent, and any interpretation suggesting otherwise is hereby retracted. This clarification, however, does not alter the underlying crisis: the DEA's marijuana manufacturing quota system is fundamentally broken. Despite a supposed expansion of DEA licenses, no registrant-except MMJ-has produced sufficient pharmaceutical-grade cannabis to support a single FDA-compliant clinical trial. The Devastating Reality: Maridose (Maine): Only 1,100 sq. ft. of space, not growing. Bright Green Corp: Surrendered its registration without ever planting a crop. Royal Emerald Pharmaceuticals: Inactive and facing financial distress. Groff NA Hemplex & Scottsdale Research Institute: No active cultivation for clinical trials. BRC: Producing quantities far below clinical thresholds. University of Mississippi: Continues to grow substandard, research-incompatible marijuana. MMJ remains the only federally compliant entity actively pursuing the cultivation of strain-specific, pharmaceutical-grade cannabis for FDA-approved clinical trials targeting Huntington's Disease and Multiple Sclerosis. Yet, for over seven years, the DEA has obstructed MMJ's efforts through unconstitutional administrative proceedings, arbitrary quotas, and a bureaucratic "Catch-22" that demands documentation (BFSA) which is unattainable without the very registration the DEA refuses to grant. A Constitutional Crisis Exposed The Supreme Court's rulings in Axon v. FTC and Jarkesy v. SEC have now exposed the DEA's internal administrative law judge (ALJ) system as an unconstitutional charade. Despite this, DEA legal counsel Aarathi Haig continues to defend a system the Department of Justice has now abandoned. Former Chief ALJ John "McLooney" Mulrooney has since retired, leaving behind what critics call a "legal dumpster fire." MMJ's legal exceptions, filed July 3, 2025, detail the agency's structural bias, retroactive sabotage, and deliberate obstruction of medical research. "We followed every law, built the FDA-inspected facility, and secured our clinical approvals," said Duane Boise, CEO of MMJ International Holdings. "What the DEA calls regulation is nothing more than bureaucratic revenge." The Time for Reckoning is Now With the confirmation of incoming DEA Administrator Terrance Cole, the opportunity for reform has arrived. The DEA must choose between outdated drug war politics and advancing public health. This demands immediate action: Fire entrenched obstructionists like Thomas Prevoznik. Investigate Aarathi Haig for perpetuating unconstitutional legal processes. Transfer oversight of cannabis research to the FDA, where science-not sabotage-will guide policy. "The DEA has spent a decade fortifying a broken system that protects monopolies, obstructs innovation, and ignores public safety disasters like the Assured Testing Labs scandal in Massachusetts," said Boise. "America doesn't need another anti-marijuana crooner in a suit-it needs a leader who will stand up to this agency's sabotage and put patients first." MMJ International Holdings remains committed to factual accuracy and will continue to expose systemic failures that endanger patients, stifle science, and betray the public trust. MMJ is represented by attorney Megan Sheehan. CONTACT:Madison HiseyMHisey@ SOURCE: MMJ International Holdings View the original press release on ACCESS Newswire Sign in to access your portfolio
